Skip to main content
HairCited

Microneedling for Alopecia Areata

A

Based on 34 studies (1 meta-analysis, 9 RCTs) with 1,908 total participants. 25/34 studies show positive effects.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

The Bottom Line

Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.

  • 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
  • Works by creating micro-injuries that stimulate healing responses and improve drug absorption
  • Most effective when combined with topical agents like corticosteroids or vitamin D3
  • Both professional clinical procedures and at-home derma rollers have been studied

Key Study Findings

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Effect: None None
retrospective cohort n=7 Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip vs: Placebo Effect: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement None
randomized controlled trial n=24 18 weeks Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals vs: Placebo Effect: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Effect: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
animal study 2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment vs: Placebo Effect: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa None

Key Statistics

34

Studies

1908

Participants

Positive

A

Grade

Referenced Papers

The Journal of … 2024 2 citations
Dermatology and therapy 2022 43 citations
Journal of the … 2020 10 citations
Proceedings (Baylor University. … 2020 8 citations
Journal of the … 2018 114 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

hairloss:
1.5 mm depth, weekly sessions

Upper limit: Not applicable

Dosages Studied in Research

Dosage Duration Effect N
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip -- Positive 7
None -- Mixed --
Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals 18 weeks Neutral 24
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment 2 weeks Positive --
Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste -- Positive --
Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week 12 weeks Mixed 60

Best taken: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Reported Side Effects

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Known Interactions

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Tolerable upper intake: Not applicable

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Microneedling help with Alopecia Areata?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that Microneedling may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Microneedling should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Microneedling?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Microneedling and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.